Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03222609
Brief Title: A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis (REFINE)

First Submitted : July 17, 2017
First Submitted that Met QC Criteria : July 17, 2017
First Posted : July 19, 2017

Last Update Submitted that Met QC Criteria : June 9, 2021
Last Update Posted : June 11, 2021